Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (121-130 of 512) with videos related to

Pageof 52
Sort By:
Investigational New Drugs|April 4, 2009
Proteinuria and proximal tubule lesions induced by an anti-integrin monoclonal antibody treatment: case reportAndrea Gombos, Hassan Izzedine, Benjamin Besse, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 3, 2009
Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosisBenjamin Besse, Dominique Grunenwald, Aude Fléchon, et al.
Bulletin Du Cancer|March 7, 2006
[Cannabis and cancer]Stéphane Vignot, Benjamin Besse, Thibault de la Motte Rouge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2016
Brain Radionecrosis Treated with Bevacizumab in a Patient with Resected Squamous Cell Carcinoma of the LungJordi Remon, Cécile Le Péchoux, Caroline Caramella, et al.
The Lancet. Oncology|September 30, 2021
Late phase 1 studies: concepts and outcomesJose Carlos Benitez, Arthur Geraud, Matthieu Texier, et al.
Onkologie|July 16, 2010
Rhinitis in patients treated with a combination of an mTOR inhibitor and an EGFR inhibitorVirginie Prulière-Escabasse, Carlos Gomez-Roca, Estelle Escudier, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 23, 2011
Long-term outcome of pleuropneumonectomy for Masaoka stage IVa thymomaDominique Fabre, Elie Fadel, Sacha Mussot, et al.
Cancer Treatment Reviews|March 26, 2017
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibitionFrancesco Facchinetti, Giulio Rossi, Emilio Bria, et al.
Journal of Surgical Oncology|March 25, 2018
Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?Stéphane Collaud, Bastien Provost, Benjamin Besse, et al.
Nature Reviews. Clinical Oncology|October 13, 2021
Tumour burden and efficacy of immune-checkpoint inhibitorsFilippo G Dall'Olio, Aurélien Marabelle, Caroline Caramella, et al.
Pageof 52

Showing results (121-130 of 512) with videos related to

Sort By:
Pageof 52
Investigational New Drugs|April 4, 2009
Proteinuria and proximal tubule lesions induced by an anti-integrin monoclonal antibody treatment: case reportAndrea Gombos, Hassan Izzedine, Benjamin Besse, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 3, 2009
Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosisBenjamin Besse, Dominique Grunenwald, Aude Fléchon, et al.
Bulletin Du Cancer|March 7, 2006
[Cannabis and cancer]Stéphane Vignot, Benjamin Besse, Thibault de la Motte Rouge, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2016
Brain Radionecrosis Treated with Bevacizumab in a Patient with Resected Squamous Cell Carcinoma of the LungJordi Remon, Cécile Le Péchoux, Caroline Caramella, et al.
The Lancet. Oncology|September 30, 2021
Late phase 1 studies: concepts and outcomesJose Carlos Benitez, Arthur Geraud, Matthieu Texier, et al.
Onkologie|July 16, 2010
Rhinitis in patients treated with a combination of an mTOR inhibitor and an EGFR inhibitorVirginie Prulière-Escabasse, Carlos Gomez-Roca, Estelle Escudier, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 23, 2011
Long-term outcome of pleuropneumonectomy for Masaoka stage IVa thymomaDominique Fabre, Elie Fadel, Sacha Mussot, et al.
Cancer Treatment Reviews|March 26, 2017
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibitionFrancesco Facchinetti, Giulio Rossi, Emilio Bria, et al.
Journal of Surgical Oncology|March 25, 2018
Should surgery be part of the multimodality treatment for stage IIIB non-small cell lung cancer?Stéphane Collaud, Bastien Provost, Benjamin Besse, et al.
Nature Reviews. Clinical Oncology|October 13, 2021
Tumour burden and efficacy of immune-checkpoint inhibitorsFilippo G Dall'Olio, Aurélien Marabelle, Caroline Caramella, et al.
Pageof 52